Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Basiliximab patent?

See the DrugPatentWatch profile for Basiliximab

Which patents cover basiliximab, and who owns them?

Basiliximab is sold under the brand name Simulect. Patent ownership and the specific patent numbers depend on the jurisdiction (country) and the particular aspect claimed (the biologic itself, manufacturing process, formulations, or method-of-use). With only the query “Basiliximab patent,” there isn’t enough provided information to identify the exact patent(s) or assignee(s) with confidence.

When do basiliximab patents or exclusivity expire?

Patent and exclusivity timelines vary by country and by regulatory regime (patent term vs. regulatory exclusivity periods for biologics). Without a specific country (for example, US, EU, UK, or India) and without a patent/publication number, the exact expiration date(s) cannot be stated reliably.

Can biosimilars enter before basiliximab patent expiry?

Whether biosimilars can launch before all relevant patents expire depends on how many patents are still in force and what they cover (drug substance vs. device/formulation vs. method claims), plus country-specific biosimilar entry rules. In practice, biosimilar approval can be granted without needing every patent to be expired, but marketing launch is often blocked by remaining “patent thickets” and enforcement actions. Exact timing again requires jurisdiction and the relevant patent list.

What’s the fastest way to find the exact basiliximab patent(s)?

If you share any of the following, it becomes possible to pinpoint the relevant patents and expiry dates:
- Country/region (e.g., US or EU)
- Brand/generic target (Simulect is basiliximab)
- A known patent number or application/publication number
- The manufacturer you care about (originator vs. a specific biosimilar company)

What if you meant “patent expiry” for a specific market (US vs EU)?

In the US and EU, “exclusivity” can refer to more than one concept (patent term, regulatory data exclusivity, and other protections). Exact dates differ by market, so the answer changes depending on where you want the timeline.

Sources

No sources were provided with the question, so I can’t cite specific patent documents or expiry dates.



Other Questions About Basiliximab :

Basiliximab cost? Basiliximab cost?